AI architecture startup Maket has raised $3.4 million CAD in seed funding to enhance its design automation platform and prepare for the launch of Maket 2.0 in early 2026.
AI architecture startup Maket has raised $3.4 million CAD in seed funding to enhance its design automation platform and prepare for the launch of Maket 2.0 in early 2026.
Venture capital firm Maple Bridge Ventures has closed $10.2 million CAD in the first round of its debut fund dedicated to supporting immigrant-led, early-stage technology startups in Canada.
Canadian FinTech leader Wealthsimple has announced a Series E funding round of up to $750 million CAD, propelling the company to a $10 billion post-money valuation — double its $5 billion valuation from just one year ago.
A new player is emerging in Canada’s digital finance ecosystem. Loon, a FinTech startup spun out of Toronto-based Paytrie, has raised $3 million CAD in pre-seed funding to take over and scale CADC, a Canadian dollar-backed stablecoin first launched by Paytrie in 2021.
Canadian fintech startup Cybrid has closed a $10 million USD Series A to accelerate adoption of stablecoin-based payments among financial institutions and enterprises — marking a major step toward mainstreaming blockchain-powered transactions in Canada.
After reaching profitability this summer, Felix Health is doubling down on growth. The Canadian telehealth startup has raised $53 million in growth financing to accelerate its expansion into new health categories — from menopause to weight loss — and prepare for the arrival of generic GLP-1 drugs in Canada.
Accounting automation startup Ready Plan Go has raised $750,000 in pre-seed funding to eliminate the repetitive back-office tasks that keep accountants from higher-value client work.
Impact-focused venture firm Spring Impact Capital has announced the final close of its inaugural $14 million CAD fund, aimed at backing early-stage Canadian startups developing scalable climate and health technology solutions.
Construction technology startup Provision has raised $7 million USD ($9.8 million CAD) in seed funding to develop its AI co-pilot platform, designed to help pre-construction teams minimize costly errors and accelerate project estimation.
Medical device innovator ABK Biomedical has raised $35 million USD ($49.1 million CAD) in Series D funding to bring its Eye90™ microspheres, a next-generation treatment for liver cancer, to market.
